Comorbidity prevalence among cancer patients: a population-based cohort study of four cancers

Fowler, Helen; Belot, Aurelien; Ellis, Libby; Maringe, Camille; Luque-Fernandez, Miguel Angel; Njagi, Edmund Njeru; Navani, Neal; Sarfati, Diana; Rachet, Bernard

doi:10.1186/s12885-019-6472-9

BMC Cancer

Table 1 Patient characteristics according to comorbidity status, by cancer

From: Comorbidity prevalence among cancer patients: a population-based cohort study of four cancers

	Cancer
	Colon								Rectum								Lung								Hodgkin lymphoma
	All patients		Number of patient comorbidities						All patients		Number of patient comorbidities						All patients		Number of patient comorbidities						All patients		Number of patient comorbidities
			0		1		2+				0		1		2+				0		1		2+				0		1		2+
	N	%	n	%	n	%	n	%	N	%	n	%	n	%	n	%	N	%	n	%	n	%	n	%	N	%	n	%	n	%	n	%
Sex
Male	54,425	53.2	23,455	43.1	14,887	27.4	16,083	29.6	35,630	63.2	18,782	52.7	8850	24.8	7998	22.4	91,568	55.3	29,333	32.0	25,283	27.6	36,952	40.4	4163	56.1	2907	69.8	697	16.7	559	13.4
Female	47,791	46.8	21,339	44.7	13,878	29.0	12,574	26.3	20,712	36.8	11,044	53.3	5299	25.6	4369	21.1	74,109	44.7	24,661	33.3	21,536	29.1	27,912	37.7	3257	43.9	2307	70.8	573	17.6	377	11.6
Age at cancer diagnosis (years)
15–29	769	0.8	661	86.0	103	13.4	5	0.7	207	0.4	180	87.0	22	10.6	5	2.4	178	0.1	120	67.4	52	29.2	6	3.4	2111	28.5	1885	89.3	205	9.7	21	1.0
30–44	2666	2.6	2151	80.7	416	15.6	99	3.7	1552	2.8	1302	83.9	203	13.1	47	3.0	1757	1.1	1212	69.0	435	24.8	110	6.3	1660	22.4	1412	85.1	194	11.7	54	3.3
45–59	11,971	11.7	8035	67.1	2619	21.9	1317	11.0	9597	17.0	7143	74.4	1635	17.0	819	8.5	19,923	12.0	10,768	54.0	5574	28.0	3581	18.0	1461	19.7	1001	68.5	288	19.7	172	11.8
60–74	42,166	41.3	20,696	49.1	11,696	27.7	9774	23.2	25,230	44.8	14,073	55.8	6421	25.4	4736	18.8	75,085	45.3	25,973	34.6	22,241	29.6	26,871	35.8	1398	18.8	651	46.6	366	26.2	381	27.3
75–90	44,644	43.7	13,251	29.7	13,931	31.2	17,462	39.1	19,756	35.1	7128	36.1	5868	29.7	6760	34.2	68,734	41.5	15,921	23.2	18,517	26.9	34,296	49.9	790	10.6	265	33.5	217	27.5	308	39.0
Deprivation group (IMD income)
Least deprived	22,411	21.9	10,864	48.5	6331	28.2	5216	23.3	11,879	21.1	6839	57.6	2939	24.7	2101	17.7	23,066	13.9	8589	37.2	6528	28.3	7949	34.5	1339	18.0	980	73.2	217	16.2	142	10.6
2	22,623	22.1	10,484	46.3	6303	27.9	5836	25.8	12,222	21.7	6810	55.7	3031	24.8	2381	19.5	28,411	17.1	9913	34.9	8025	28.2	10,473	36.9	1428	19.2	1013	70.9	222	15.5	193	13.5
3	21,591	21.1	9460	43.8	6123	28.4	6008	27.8	11,750	20.9	6219	52.9	2970	25.3	2561	21.8	32,822	19.8	10,980	33.5	9365	28.5	12,477	38.0	1462	19.7	1018	69.6	263	18.0	181	12.4
4	19,940	19.5	8118	40.7	5614	28.2	6208	31.1	11,266	20.0	5646	50.1	2838	25.2	2782	24.7	39,220	23.7	12,356	31.5	10,885	27.8	15,979	40.7	1618	21.8	1132	70.0	277	17.1	209	12.9
Most deprived	15,651	15.3	5868	37.5	4394	28.1	5389	34.4	9225	16.4	4312	46.7	2371	25.7	2542	27.6	42,158	25.4	12,156	28.8	12,016	28.5	17,986	42.7	1573	21.2	1071	68.1	291	18.5	211	13.4
TOTAL	102,216	100.0	44,794	43.8	28,765	28.1	28,657	28.0	56,342	100.0	29,826	52.9	14,149	25.1	12,367	21.9	165,677	100.0	53,994	32.6	46,819	28.3	64,864	39.2	7420	100.0	5214	70.3	1270	17.1	936	12.6

Abbreviations - IMD Indices of Multiple Deprivation

Back to article page

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com